US Patent Issued to Dana-Farber Cancer Institute on Nov. 25 for "Cancer vaccine compositions and methods for using same to prevent and/or treat cancer" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,665, issued on Nov. 25, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Cancer vaccine compositions and methods for using same to prevent and/or treat cancer" was invented by Jean Zhao (Brookline, Mass.), Yunneng Tang (Brookline, Mass.) and Xin Cheng (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is based, in part, on cancer vaccine compositions that comprise PTEN- and p53-deficient cancer cells with activated TGFBeta-Smad/p63 signaling pathway, and methods for using same to prevent and/or treat cancer."

The patent was filed on July 14, 2020, under Application No. 17/626,263.

*For further inform...